Latest news

Results from the bile duct cancer study will be presented as late-breaking news at United European Gastroenterology Week

Posted on Oct 17, 2016

Oslo, October 17, 2016 – PCI Biotech today announced that an abstract with results from the phase I bile duct cancer study has been selected for oral presentation as late-breaking news at the United European Gastroenterology (UEG) Week. The results will be presented by Dr. Alexander Dechêne, University Hospital Essen, Germany, who is one of […]

PCI Biotech to present poster at the Second International Cancer Immunotherapy Conference

Posted on Sep 23, 2016

Oslo, September 23, 2016 – PCI Biotech will present a poster at CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference 2016. This year’s event is called “Translating Science into Survival” and is held at the Sheraton Times Square Hotel and the New York Hilton Midtown in New York City, September 25-28, 2016. The company will be represented by […]

PCI Biotech to present phase I results at Nordic Life Science Days 2016

Posted on Sep 13, 2016

Oslo, September 13, 2016 – PCI Biotech will present at Nordic Life Science Days 2016 on Wednesday, September 14, 2016, 17:00 local time at Stockholm Waterfront Congress Center (room 24/25 on level 2), Stockholm, Sweden. The presentation is attached and includes results from the phase I bile duct cancer study. The presentation will be held […]